정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1976 | Recruiting | Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19 | COVID-19 | Drug: Suspension of heat killed (autoclaved) Mycobacterium w Other: Placebo |
Phase 3 | Cadila Pharnmaceuticals, Council of Scientific and Industrial Research, India | INDUSTRY | 4000 | All | 18 Years | All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India Post Graduate Institute of Medical Education and Research, Chandigarh, India All lndia Institute of Medical Science, Delhi, Delhi, India |
| 1975 | Completed | Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia | COVID-19 | Drug: Tocilizumab | Phase 2 | Fundacion SEIMC-GESIDA, Roche Pharma AG, Dynamic Science S.L. | OTHER | 495 | All | 18 Years | Hospital Universitario de Cabuenes, Gijon, Asturias, Spain Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain Hospital Sant Joan de Deu de Manresa, Manresa, Barcelona, Spain Hospital de Mataro, Mataro, Barcelona, Spain Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain Hospital Universitario Marques Valdecilla, Santander, Cantabria, Spain Hospital Publico General del Tomelloso, Tomelloso, Ciudad Real, Spain Hospital Jerez de la Frontera, Jerez De La Frontera, Cadiz, Spain Hospital Universitari Son Espases, Palma De Mallorca, Islas Baleares, Spain Hospital Universitario Fundacion Alcorcon, Alcorcon, Madrid, Spain Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain Hospital Universitario de Getafe, Getafe, Madrid, Spain Hospital Rey Juan Carlos, Mostoles, Madrid, Spain Hospital Universitario Rey Juan Carlos, Mostoles, Madrid, Spain Hospital Universitario Infanta Sofia, San Sebastian De Los Reyes, Madrid, Spain Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain Hospital Nuestra Senora del Prado, Talavera De La Reina, Toledo, Spain Complejo Hospitalario Universitario de Albacete, Albacete, Spain Hospital Infanta Cristina, Badajoz, Spain Hospital Clinic i Provincial Barcelona, Barcelona, Spain Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Hospital Universitario de Burgos, Burgos, Spain Hospital Universitario Dr. Josep Trueta, Gerona, Spain Hospital Universitario Clinico San Cecilio, Granada, Spain Hospital Universitario Virgen de las Nieves, Granada, Spain Hospital General Universitario Gregorio Maranon, Madrid, Spain Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain Hospital Universitario HM Sanchinarro, Madrid, Spain Hospital Universitario Infanta Leonor, Madrid, Spain Hospital Universitario Ramon y Cajal, Madrid, Spain Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain Hospital Regional Universitario de Malaga, Malaga, Spain Complexo Hospitalario Universitario de Ourense, Orense, Spain Hospital Universitario Salamanca, Salamanca, Spain Hospital Universitario Virgen de la Macarena, Sevilla, Spain Hospital Universitario Virgen del Rocio, Sevilla, Spain Hospital Virgen de la Salud, Toledo, Spain Hospital Clinico Universitario de Valencia, Valencia, Spain Hospital Universitari i Poliectenic La Fe, Valencia, Spain Hospital Universitario Dr. Peset, Valencia, Spain Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain Hospital Universitario Miguel Servet, Zaragoza, Spain |
| 1974 | Completed | Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection | COVID-19 Infection | Drug: metenkefalin + tridecactide Drug: The standard of care |
Phase 3 | Bosnalijek D.D | INDUSTRY | 120 | All | 18 Years | Clinical Center University of Sarajevo, Sarajevo, Sarajevo Canton, Bosnia and Herzegovina University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina Hospital Travnik, Travnik, Bosnia and Herzegovina Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina |
| 1973 | Recruiting | Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19 | SARS-CoV-2 Infection | Drug: Emtricitabine/Tenofovir Disoproxil Fumarate 200 MG-245 MG Oral Tablet [TRUVADA] Drug: Baricitinib + dexamethasone Drug: Dexamethasone |
Phase 3 | Instituto de Investigacion Hospital Universitario La Paz | OTHER | 2193 | All | 18 Years | Hospital Universitario La Paz, Madrid, Spain |
| 1972 | Not yet recruiting | Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers | Sars-CoV2 | Biological: RUTI® vaccine Biological: Placebo |
Phase 3 | Fundacio Institut Germans Trias i Pujol | OTHER | 315 | All | 18 Years | Hospital Universitari Germans Trias i Pujol UBP Riscos Laborals, Badalona, Barcelona, Spain Hospital de la Santa Creu i Sant Pau, Barcelona, Spain |
| 1971 | Recruiting | Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection | SARS-CoV 2 | Biological: Hyperimmune plasma Drug: Standard of care for SARS-CoV-2 infection |
Phase 2 | Andalusian Network for Design and Translation of Advanced Therapies | OTHER | 72 | All | 18 Years ~ 80 Years | Hospital U. Jerez de la Frontera, Jerez de la Frontera, Cadiz, Spain Hospital U. Puerto Real, Puerto Real, Cadiz, Spain Hospital Costa del Sol, Marbella, Malaga, Spain Hospital U. Torrecardenas, Almeria, Spain Hospital U. Puerta del Mar, Cadiz, Spain Hospital U. Virgen de las Nieves, Granada, Spain Hospital U. San Cecilio, Granada, Spain Hospital Juan Ramon Jimenez, Huelva, Spain Hospital Regional U. de Malaga, Malaga, Spain Hospital U. Virgen de la Victoria, Malaga, Spain Hospital Unversitario Virgen Macarena, Sevilla, Spain Hospital Universitario Virgen del Rocio, Sevilla, Spain Hospital U. Nuestra Senora de Valme, Sevilla, Spain Hospital San Juan de Dios, Sevilla, Spain |
| 1970 | Active, not recruiting | Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) | COVID-19 Virus Infection | Biological: Inactivated SARS-CoV-2 vaccine (Vero cell) Biological: Placebo/Aluminum Adjuvant of Inactivated SARS-CoV-2 vaccine |
Phase 3 | Laboratorio Elea Phoenix S.A., Beijing Institute of Biological Products Co Ltd., China National Biotec Group Company Limited, Fundacion Huesped | INDUSTRY | 3000 | All | 18 Years ~ 85 Years | Fundacion Huesped, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina Vacunar Liniers, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina Vacunar Canitas, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina Vacunar Coghlan, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina |
